OrbiMed launches $222M Israeli life sciences fund; Roche scouting for new sequencing tech;

 @FierceBiotech: Survey: Pharma lags peers in gaining trust via social media. Article | Follow @FierceBiotech

 @JohnCFierce: Biota (Australia) to merge into U.S. biotech Nabi and move to U.S. Release | Follow @JohnCFierce

 @RyanMFierce: Nice visualization of biotech VC trends dating back to '95. Graphics | Follow @RyanMFierce

> OrbiMed has established a $222 million fund to invest in Israeli drug developers. OrbiMed Israel Partners Limited Partnership includes an anchor investment provided by the Israeli government. Release

> A Swiss newspaper reports that Roche ($RHHBY) is approaching several universities to see if it can acquire new sequencing technology. The pharma giant reported this morning that it is returning all the shares tendered on Illumina ($ILMN) after it refused to extend its takeover offer at the end of last week. Story

> Ironwood ($IRWD) announced this morning that the FDA has extended its review of linaclotide by three months. Release

> A top Johnson & Johnson ($JNJ) executive says the pharma giant is open to the idea of expanding its partnership with Vertex ($VRTX) on the hep C front. Both companies are engaged in developing interferon-free therapies and a number of companies are testing various combo regimens to come up with new cocktail treatments. Story

Pharma News

 @FiercePharma: Will lame-duck Congress go after pharma's advertising deduction? Ad lobbyists keeping an eye--AdAge. More | Follow @FiercePharma

> China sweeps up dozens in whirlwind drug-capsule probe. News

> Amylin's up for bid; who'll step in line? More

Medical Devices News

@FierceMedDev: Nephros taps John Houghton as president, CEO. Release | Follow @FierceMedDev

> Spurned by Illumina, Roche may be eyeing universities for gene-sequencing tech. Story

> Singapore streamlines fees, approval times for low-risk devices. Article

> FDA trashes European regulatory process. More

Biotech IT News

> NextBio moves genetic analysis software into clinical R&D territory. News

> Survey: Pharma lags peers in gaining trust via social media. More

> GAO report: FDA's IT modernization 'in jeopardy.' Story

> Google VC fuels Series A round for pharma software startup. Article

And Finally... Two bipartisan groups have been gaining support for their calls to increase funding at the NIH. Story

Suggested Articles

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.

Gilead presented studies at AASLD showing how noninvasive testing and machine learning could improve diagnostics and drug development for NASH.